We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

HUMAN GMBH

HUMAN offers a broad portfolio of in vitro diagnostic products with more than 400 products in 12 areas covering the w... read more Featured Products: More products

Download Mobile App





HUMAN Diagnostics Launches Next Generation Clinical Chemistry Instruments

By LabMedica International staff writers
Posted on 04 Feb 2025

HUMAN Diagnostics (Wiesbaden, Germany) is launching its next-generation clinical chemistry instruments at Medlab Middle East 2025. More...

The launch is under the motto “Primed for Precision. Built for Performance” and will spotlight the next-generation HumaStar 300SR, HumaStar 200, and the HumaLyzer Primus NG, offering laboratories cutting-edge performance, enhanced efficiency, and robust reliability. These instruments cater to diverse throughput needs, empowering labs to deliver accurate and timely results critical to patient care.

The updated HumaStar 300SR and HumaStar 200 instruments offer improved performance and reliability with an advanced cuvette wash station and, now new, clot detection (HumaStar 300SR only). The upgraded pipetting unit ensures higher precision for low volumes and better repeatability, while V-shaped reaction cuvettes reduce reagent use and operating costs. Additionally, an integrated 2D barcode scanner simplifies the import of QC and calibration target values, streamlining operations; the 3-color LED status illumination provides intuitive and easy monitoring.

The HumaLyzer Primus NG is a user-friendly, semi-automated solution that is ideal for laboratories in resource-limited settings with a large 7-inch touchscreen interface enhancing usability. Visitors to HUMAN’s booth can explore these next-gen instruments and view live demonstrations that showcase their capabilities and ease of use. Additionally, HUMAN is also showcasing the HumaCombilyzer portable, semi-automated urine test strip analyzer which is ideal for in-office and more rural healthcare settings. Alongside, HUMAN is showcasing HumaCombina urine test strips which enable fast and effortless assessment of urine status, supporting the detection of pathological changes.

“HUMAN’s clinical chemistry instruments have long been trusted for their precision and reliability. With this launch, we’re setting new standards for laboratory diagnostics by combining German engineering excellence with the latest technological advancements,” said Dr. Christine Hettmann-Dreuw, VP of Marketing & Strategic Purchase at HUMAN Diagnostics.


Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
HAV Rapid Test
OnSite HAV IgG/IgM Rapid Test
New
Enterovirus Test
Quanty Enterovirus System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.